MedPage Today on MSN

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
Fierce Biotech

FDA approves next-gen prostate cancer PSA test from Cleveland Diagnostics

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
MedPage Today on MSN

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Fred Hutchinson Cancer Center

Colorado patient chooses proton therapy following prostate cancer surgery

After surgery for prostate cancer, Todd Elworthy’s PSA came back elevated. Radiation was advised as the next step and Elworthy looked into a Fred Hutch clinical trial and proton therapy. Though he ...
Hospital NewsOpinion

Despite Movember push, rates of incurable prostate cancer are rising as screening is abandoned

Understand the rising rates of incurable prostate cancer in Canada and the importance of self-advocacy for testing.